Skip to content

Apogee Therapeutics, Inc. APGE Prepaid & Other Current

Prepaid & Other Current at other companies

Alkermes logo
AlkermesALKS
$16.17M+1,816%

Other financials

Income statement

See full
Operating income-$82.8M-31.2%
Net income-$74.1M-33.9%
EPS (diluted)-$1.06-11.6%

Balance sheet

See full
Cash & equivalents$451.8M+323%
Total debt$8.0M-31.9%
Total assets$1.3B+81.1%

Cash flow

See full
Operating cash flow-$55.6M-14.6%
CapEx$62.0K
Free cash flow-$62.8M+7.3%

Valuation

See full
Market cap$6.81B+189%
Enterprise value$6.37B+181%

Returns & leverage

See full
Current ratio32.6×+16.8×

Where this comes from

Reported directly by Apogee Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidExpensesOther.

The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Apogee Therapeutics, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Apogee Therapeutics, Inc.'s prepaid & other current?
Apogee Therapeutics, Inc. (APGE) reported prepaid & other current of $2.49M in Q1 2026.
How has Apogee Therapeutics, Inc.'s prepaid & other current changed year-over-year?
Apogee Therapeutics, Inc.'s prepaid & other current increased by 378.2% year-over-year, from -$895K to $2.49M.
What does prepaid & other current mean?
This reflects the net change in cash outflows for expenses paid in advance or other short-term assets that have not yet been recognized as costs in the income statement. An increase in this balance indicates a use of cash, while a decrease indicates a source of cash as those assets are consumed. Monitoring this helps assess the efficiency of working capital management and the timing of operational expenditures.